FDA recall, , Moderate risk
LifeSouth Community Blood Centers Apheresis Red Blood Cells, Leukocytes Reduced
Apheresis Red Blood Cells, Leukocytes Reduced were labeled as leukocytes reduced but failed the monthly QC residual white blood cell count.
Recall ended Jul 2, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
LifeSouth Community Blood Centers, Inc. recalled Apheresis Red Blood Cells, Leukocytes Reduced, which were labeled as leukocytes reduced but failed the monthly QC residual white blood cell count. The recall began on April 2, 2025, and the FDA added it to its Enforcement Report on July 2, 2026. The affected product was distributed in Alabama.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Apheresis Red Blood Cells, Leukocytes Reduced
Recall details
- Company began the recall
- Sold in
- Company
- LifeSouth Community Blood Centers, Inc.
- Hazard
- Labeling error
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99159
- Recall number
- B-0141-2026
All recalls from LifeSouth Community Blood Centers, Inc.
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary
Archived
